Streetbeat News

Products Services

DYAI

Dyadic International and Byorna have entered into a development and commercialization agreement to work on disruptive bioproduction technologies that will exploit the therapeutic potential of messenger RNA.

Portfolio Pulse from Benzinga Newsdesk

September 26, 2023 | 12:38 pm

ROIV

Roivant Sciences' shares are trading higher following the announcement of initial IMVT-1402 Phase 1 SAD and 300 mg subcutaneous MAD results.

Portfolio Pulse from Benzinga Newsdesk

September 26, 2023 | 12:37 pm

FEMY

IMVT

SLNO

Soleno Therapeutics (SLNO) announced positive results from a study of DCCR for Prader-Willi Syndrome. Femasys Inc. (FEMY) received FDA clearance to market FemaSeed, a new infertility treatment. Immunovant (IMVT) announced positive initial results from a phase 1 study of IMVT-1402.

Portfolio Pulse from ryanfaloona@benzinga.com

September 26, 2023 | 12:35 pm

IMVT

Immunovant's shares are trading higher following the announcement of initial IMVT-1402 Phase 1 SAD and 300 mg subcutaneous MAD results.

Portfolio Pulse from Benzinga Newsdesk

September 26, 2023 | 12:34 pm

VERU

Veru has reached an agreement with the FDA to conduct a Phase 3 clinical trial for Sabizabulin for a broader indication, including all hospitalized adult patients with any type of virus-induced Acute Respiratory Distress Syndrome (ARDS). The study, which could begin as early as Q4 2023, will replace the second confirmatory Phase 3 COVID-19 study.

Portfolio Pulse from Benzinga Newsdesk

September 26, 2023 | 12:34 pm

BB

Mitsubishi Electric has chosen BlackBerry's IVY platform to power its new in-vehicle system, FLEXConnect. The collaboration aims to improve road safety by using sensor data to anticipate safety risks, reduce driver distractions, and highlight potential driving hazards.

Portfolio Pulse from Benzinga Newsdesk

September 26, 2023 | 12:29 pm

TMUS

T-Mobile (NASDAQ:TMUS) has announced its second corporate venture capital fund aimed at fueling the development of next-generation connected products and services. The fund will support private mid- and growth-stage companies to leverage T-Mobile's 5G network for future growth areas.

Portfolio Pulse from Benzinga Newsdesk

September 26, 2023 | 12:25 pm

MO

PEP

Canadian marijuana and liquor retail company, 1CM Inc., has expanded its retail portfolio to include tobacco, vape, and consumer packaged goods products. The company has started retailing cigarettes and vape products as an authorized retailer of Imperial Tobacco Canada, a subsidiary of British American Tobacco, and Rothmans Benson & Hedges, a subsidiary of Altria. It has also begun retailing CPG products from PepsiCo, Frito-Lay, Parmalat & Canada Bread. Additionally, 1CM has started producing its private label Vodka and Vodka Iced Tea under the brand 'EPIC MILFF'.

Portfolio Pulse from Nina Zdinjak

September 26, 2023 | 12:22 pm

BBLG

Bone Biologics (BBLG) plans to conduct a 30-patient pilot study in Australia later this year.

Portfolio Pulse from Benzinga Newsdesk

September 26, 2023 | 12:22 pm

BMRA

Biomerica, Inc. (NASDAQ:BMRA) announced that the Dubai government has approved insurance reimbursement for its EZ Detect colorectal disease at-home screening test. The test is designed to detect early signs of colorectal cancer and other colorectal diseases. The approval will make the test more accessible and affordable for individuals in Dubai.

Portfolio Pulse from Benzinga Newsdesk

September 26, 2023 | 12:21 pm